Xijing Hospital of Digestive Diseases
Xijing Hospital of Digestive Diseases
Explore linked clinical trials.22 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease | Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Not applicable | 2026-09-22 | NCT07582731 | |
| Advanced Adenoma Detection With 3D Imaging Device During Colonoscopy | colorectal adenoma | Recruiting | Not applicable | 2026-08-18 | NCT06924489 | |
| Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time | Digestive System Diseases, Digestive System Neoplasms, Hemorrhage, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Not applicable | 2026-08-17 | NCT07401303 | |
| Effect of Questionnaires and Feedback on the Patient Compliance for Endoscopic Surveillance After ESD | Patient Compliance | Recruiting | Not applicable | 2026-08-17 | NCT06092281 | |
| Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC) | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Active, not recruiting | Early phase 1 | 2026-07-29 | NCT07104201 | |
| Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis(UPRISE) | Acute Severe Ulcerative Colitis | Recruiting | Phase 4 | 2026-04-24 | NCT07550673 | |
| Optimization of taVNS Intervention Strategies for Refractory Constipation | Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorder | Recruiting | Not applicable | 2026-01-15 | NCT07344402 | |
| Transcranial Alternating Current Stimulation for Refractory Constipation With Somatic Symptom Disorder | Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorder | Recruiting | Not applicable | 2026-01-09 | NCT07323407 | |
| Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Recruiting | Phase 3 | 2026-01-08 | NCT06755541 | |
| Fenofibrate in Primary Biliary Cholangitis: a Real World Study | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Recruiting | Phase 3 | 2026-01-08 | NCT06755151 | |
| Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Recruiting | Phase 3 | 2026-01-08 | NCT05751967 | |
| Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Recruiting | Phase 2 / Phase 3 | 2026-01-08 | NCT05749822 | |
| Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia | anxiety, anxiety disorder, depressive disorder, psychiatric disorder | Recruiting | Phase 4 | 2026-01-05 | NCT07187492 | |
| Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia | anxiety, anxiety disorder, depressive disorder, psychiatric disorder | Recruiting | Phase 4 | 2026-01-05 | NCT07182890 | |
| FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Recruiting | Phase 3 | 2025-12-29 | NCT07296458 | |
| The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Enrolling by invitation | Not applicable | 2025-12-02 | NCT07257588 | |
| Efficacy and Safety of Berberine for Gastric Intestinal Metaplasia | gastric intestinal metaplasia | Not yet recruiting | Phase 4 | 2025-09-04 | NCT07129460 | |
| Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation | Medically Unexplained Symptoms, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorder | Recruiting | Not stated | 2025-07-24 | NCT06221722 | |
| Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Not stated | 2025-07-03 | NCT06962020 | |
| Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment | Helicobacter Pylori Infection Chronic Gastrit | Active, not recruiting | Phase 4 | 2025-07-03 | NCT06523764 | |
| Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Recruiting | Phase 2 / Phase 3 | 2025-07-02 | NCT06365424 | |
| Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction | Siewert Type II Adenocarcinoma of Esophagogastric Junction | Recruiting | Not applicable | 2024-11-08 | NCT05356520 |